Cross Reactivity of Acute Generalized Exanthematous Pustulosis Among Proton Pump Inhibitors: Case Report
Abstract
Introduction Acute generalized exanthematous pustulosis (AGEP) is an acute pustular eruption characterized by widespread nonfollicular sterile pustules. AGEP is a rare adverse drug reaction with an incidence of 1 to 5 cases per million per year. This condition was accidentally discovered in a patient treated with two different proton pump inhibitors (PPIs) consecutively. Case Presentation A 47-year-old male developed pustulosis within a couple of hours after being injected with pantoprazole 40 mg. After 3 days of stopping pantoprazole, the patient was injected with lansoprazole 30 mg, and pustulosis redeveloped. Discussion Several studies have reported that pantoprazole can induce AGEP in sensitive patients, but the incidence is rare. In the current case, two different PPI drugs induced the condition in the same patient. This showed cross-reactivity between pantoprazole and lansoprazole in inducing AGEP. The current study is the first case report on cross-reactivity of PPIs in AGEP. According to previous results, cross-reactivity in PPIs is largely due to a similar chemical structure. Omeprazole, esomeprazole, and pantoprazole have changed their benzimidazole rings, while lansoprazole and rabeprazole have modified their pyridine rings. Therefore, cross-reactivity is often observed within the same group of benzimidazoles or pyridines. In the current case, the cross-reactivity cannot be explained by those patterns. A safe alternative PPI can be identified by a skin test, which…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.